Latest Breaking News On - News ratings for catalyst pharmaceuticals daily - Page 8 : comparemela.com

Brokerages Set Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Price Target at $22 90

Brokerages Set Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Price Target at $22 90
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerCatalyst pharmaceuticals incAnalyst recommendations for catalyst pharmaceuticalsCatalyst pharmaceuticalsNews ratings for catalyst pharmaceuticals dailyAdvisory services networkCatalyst pharmaceuticals stock downCantor fitzgeraldNisa investment advisorsToth financial advisory corpHedge funds weigh in on catalyst pharmaceuticalsGet free reportMarketbeat ratingsPharmaceuticals stock downServices network

Catalyst Pharmaceuticals (NASDAQ:CPRX) Rating Reiterated by HC Wainwright

Catalyst Pharmaceuticals (NASDAQ:CPRX) Rating Reiterated by HC Wainwright
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United statesPatrickj mcenanyPiper sandlerCatalyst pharmaceuticalsAdvisory servicesCatalyst pharmaceuticals stockCatalyst pharmaceuticals incNavellier associates incInsider activity at catalyst pharmaceuticalsCantor fitzgeraldJupiter asset management ltdNews ratings for catalyst pharmaceuticals dailyGet free reportAsset managementCatalyst pharmaceuticals daily

Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Receives Average Rating of Moderate Buy from Brokerages

Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Receives Average Rating of Moderate Buy from Brokerages
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerPatrickj mcenanyToth financial advisory corpCatalyst pharmaceuticalsCatalyst pharmaceuticals trading downInstitutional investors weigh in on catalyst pharmaceuticalsCatalyst pharmaceuticals incNews ratings for catalyst pharmaceuticals dailyAdvisory services networkInsider transactions at catalyst pharmaceuticalsNisa investment advisorsCantor fitzgeraldGet free reportServices networkFinancial advisory corp

Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Sees Significant Drop in Short Interest

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) saw a large decline in short interest in July. As of July 15th, there was short interest totalling 7,190,000 shares, a decline of 9.1% from the June 30th total of 7,910,000 shares. Currently, 7.2% of the company’s stock are short sold. Based on an average trading volume […]

United statesPatrickj mcenanyPiper sandlerCatalyst pharmaceuticals stock downJuncture wealth strategiesCatalyst pharmaceuticals incCatalyst pharmaceuticalsSheaff brock investment advisorsPrincipal financial group incHancock whitney corpNews ratings for catalyst pharmaceuticals dailyJupiter asset management ltdGet free reportPharmaceuticals stock downFinancial groupBrock investment advisors

Texas Permanent School Fund Corp Raises Stock Position in Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX)

Texas Permanent School Fund Corp grew its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 35.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 82,297 shares of the biopharmaceutical company’s stock after acquiring an additional 21,497 shares during the […]

Hong kongUnited statesPiper sandlerPatrickj mcenanyTexas permanent school fund corpCovestor ltdToth financial advisory corpExchange commissionNews ratings for catalyst pharmaceuticals dailyInsider transactions at catalyst pharmaceuticalsCatalyst pharmaceuticals trading downCatalyst pharmaceuticalsCatalyst pharmaceuticals incQuarter for catalyst pharmaceuticalsHong kong ltdFree report